With the development of multi-color flow cytometry (FCM) diagnostic technology and monoclonal antibody technology, flow cytometry is becoming more and more important in the diagnosis and classification of malignant hematologic diseases, especially acute leukemia and lymphoma. In order to improve the quality of the department of hematology in our province and strengthen academic exchanges in the region. According to the study, a training course on the New Progress of Flow cytometry in Clinical Application will be held in Chengdu on December 3-4, 2022. This conference is co-sponsored by Chengdu Hi-tech Medical Association and Western Theater Command General Hospital. In accordance with the requirements of targeted epidemic prevention and control, the secretariat of the Economic Society and the preparatory group of the special committee held this meeting online.

In order to further promote the development of flow cytometry and single cell diagnosis and treatment technology in multiple disciplines, improve the diagnosis and treatment ability of the whole system, and strengthen the interdisciplinary integration and development. We are very honored to have invited well-known experts, young and middle-aged scholars from all over the country and inside and outside the military to give lectures on relevant fields and carry out multi-level and multi-disciplinary exchanges. This training course is suitable for primary physicians and front-line practitioners. It is hoped that through the sharing and communication platform built by this conference, the theoretical basis and practical application ability of flow cytometry can be improved, so as to contribute to the high-quality development of the hospital.